Mkhikian, Haik http://orcid.org/0000-0003-4560-306X
Hayama, Ken L.
Khachikyan, Khachik
Li, Carey
Zhou, Raymond W.
Pawling, Judy
Klaus, Suzi
Tran, Phuong Q. N.
Ly, Kim M.
Gong, Andrew D.
Saryan, Hayk
Hai, Jasper L.
Grigoryan, David
Lee, Philip L.
Newton, Barbara L.
Raffatellu, Manuela http://orcid.org/0000-0001-6487-4215
Dennis, James W. http://orcid.org/0000-0002-0295-5877
Demetriou, Michael http://orcid.org/0000-0001-8547-5774
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI126277, R01AI114625, R01AI108917, R01AI144403)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R01AT007452)
Article History
Received: 24 March 2021
Accepted: 2 February 2022
First Online: 18 March 2022
Competing interests
: J.D. and M.D. are named as inventors on a patent application that describes GlcNAc as a biomarker for multiple sclerosis. J.D. and M.D. are named as inventors on a patent for use of GlcNAc in multiple sclerosis. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.